Nature Reviews Microbiology, volume 20, issue 5, pages 270-284

SARS-CoV-2 pathogenesis

Mart M. Lamers 1
Bart L Haagmans 1
1
 
Viroscience Department, Erasmus Medical Center, Rotterdam, Netherlands
Publication typeJournal Article
Publication date2022-03-30
Quartile SCImago
Q1
Quartile WOS
Q1
Impact factor88.1
ISSN17401526, 17401534
Microbiology
Infectious Diseases
General Immunology and Microbiology
Abstract
The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a devastating pandemic. Although most people infected with SARS-CoV-2 develop a mild to moderate disease with virus replication restricted mainly to the upper airways, some progress to having a life-threatening pneumonia. In this Review, we explore recent clinical and experimental advances regarding SARS-CoV-2 pathophysiology and discuss potential mechanisms behind SARS-CoV-2-associated acute respiratory distress syndrome (ARDS), specifically focusing on new insights obtained using novel technologies such as single-cell omics, organoid infection models and CRISPR screens. We describe how SARS-CoV-2 may infect the lower respiratory tract and cause alveolar damage as a result of dysfunctional immune responses. We discuss how this may lead to the induction of a ‘leaky state’ of both the epithelium and the endothelium, promoting inflammation and coagulation, while an influx of immune cells leads to overexuberant inflammatory responses and immunopathology. Finally, we highlight how these findings may aid the development of new therapeutic interventions against COVID-19. In this Review, Lamers and Haagmans explore recent clinical and experimental advances in understanding severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pathogenesis, interactions with host cells and the involvement of the immune system in the development of severe disease. Specifically, they focus on mechanisms underlying the development of COVID-19-associated acute respiratory distress syndrome.

Top-30

Citations by journals

5
10
15
20
25
30
Frontiers in Immunology
27 publications, 5.34%
Viruses
15 publications, 2.96%
International Journal of Molecular Sciences
12 publications, 2.37%
Scientific Reports
9 publications, 1.78%
Journal of Virology
8 publications, 1.58%
Nutrients
7 publications, 1.38%
Nature Communications
6 publications, 1.19%
Vaccines
5 publications, 0.99%
Journal of Clinical Medicine
5 publications, 0.99%
Pathogens
4 publications, 0.79%
Biomedicine and Pharmacotherapy
4 publications, 0.79%
Biomedicines
4 publications, 0.79%
Microorganisms
4 publications, 0.79%
Frontiers in Cellular and Infection Microbiology
4 publications, 0.79%
Journal of Medical Virology
4 publications, 0.79%
Life
3 publications, 0.59%
International Journal of Environmental Research and Public Health
3 publications, 0.59%
mBio
3 publications, 0.59%
Diagnostics
3 publications, 0.59%
Frontiers in Medicine
3 publications, 0.59%
Frontiers in Microbiology
3 publications, 0.59%
Biosensors
3 publications, 0.59%
Heliyon
3 publications, 0.59%
PLoS ONE
3 publications, 0.59%
ACS Infectious Diseases
3 publications, 0.59%
Biosensors and Bioelectronics
3 publications, 0.59%
Journal of Translational Medicine
3 publications, 0.59%
Science advances
3 publications, 0.59%
Nature Reviews Microbiology
2 publications, 0.4%
5
10
15
20
25
30

Citations by publishers

10
20
30
40
50
60
70
80
90
100
Multidisciplinary Digital Publishing Institute (MDPI)
95 publications, 18.77%
Elsevier
93 publications, 18.38%
Springer Nature
72 publications, 14.23%
Frontiers Media S.A.
45 publications, 8.89%
Cold Spring Harbor Laboratory
36 publications, 7.11%
Wiley
22 publications, 4.35%
American Society for Microbiology
15 publications, 2.96%
American Chemical Society (ACS)
11 publications, 2.17%
Taylor & Francis
11 publications, 2.17%
Public Library of Science (PLoS)
5 publications, 0.99%
Oxford University Press
5 publications, 0.99%
European Respiratory Society (ERS)
4 publications, 0.79%
Hindawi Limited
4 publications, 0.79%
American Association for the Advancement of Science (AAAS)
4 publications, 0.79%
Thieme
4 publications, 0.79%
Bentham Science
4 publications, 0.79%
American Thoracic Society
3 publications, 0.59%
BMJ
3 publications, 0.59%
Mary Ann Liebert
3 publications, 0.59%
Dove Medical Press
3 publications, 0.59%
PeerJ
2 publications, 0.4%
PagePress
2 publications, 0.4%
Royal Society of Chemistry (RSC)
2 publications, 0.4%
American Physiological Society
2 publications, 0.4%
American Society of Hematology
2 publications, 0.4%
Future Medicine
2 publications, 0.4%
SAGE
2 publications, 0.4%
Rockefeller University Press
2 publications, 0.4%
eLife Sciences Publications
2 publications, 0.4%
10
20
30
40
50
60
70
80
90
100
  • We do not take into account publications without a DOI.
  • Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
Share
Cite this
GOST |
Cite this
GOST Copy
Lamers M. M., Haagmans B. L. SARS-CoV-2 pathogenesis // Nature Reviews Microbiology. 2022. Vol. 20. No. 5. pp. 270-284.
GOST all authors (up to 50) Copy
Lamers M. M., Haagmans B. L. SARS-CoV-2 pathogenesis // Nature Reviews Microbiology. 2022. Vol. 20. No. 5. pp. 270-284.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1038/s41579-022-00713-0
UR - https://doi.org/10.1038/s41579-022-00713-0
TI - SARS-CoV-2 pathogenesis
T2 - Nature Reviews Microbiology
AU - Lamers, Mart M.
AU - Haagmans, Bart L
PY - 2022
DA - 2022/03/30 00:00:00
PB - Springer Nature
SP - 270-284
IS - 5
VL - 20
SN - 1740-1526
SN - 1740-1534
ER -
BibTex |
Cite this
BibTex Copy
@article{2022_Lamers,
author = {Mart M. Lamers and Bart L Haagmans},
title = {SARS-CoV-2 pathogenesis},
journal = {Nature Reviews Microbiology},
year = {2022},
volume = {20},
publisher = {Springer Nature},
month = {mar},
url = {https://doi.org/10.1038/s41579-022-00713-0},
number = {5},
pages = {270--284},
doi = {10.1038/s41579-022-00713-0}
}
MLA
Cite this
MLA Copy
Lamers, Mart M., and Bart L Haagmans. “SARS-CoV-2 pathogenesis.” Nature Reviews Microbiology, vol. 20, no. 5, Mar. 2022, pp. 270-284. https://doi.org/10.1038/s41579-022-00713-0.
Found error?